FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

1274701000168102: Bydureon BCise (exenatide 2 mg / 0.85 mL) modified release injection, 2 mL pen device (trade product unit of use)


Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3263021000168110 Bydureon BCise (exenatide 2 mg / 0.85 mL) modified release injection, 2 mL pen device (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3263031000168113 Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Is a Bydureon BCise true Inferred relationship Some
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Is a exenatide 2 mg/0.85 mL modified release injection, 2 mL pen device true Inferred relationship Some
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Is a trade product unit of use true Inferred relationship Some
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has manufactured dose form modified release injection true Inferred relationship Some
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has unit of use pen device true Inferred relationship Some 469073033
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has intended active ingredient exenatide true Inferred relationship Some 469073032
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has Australian BoSS exenatide true Inferred relationship Some 469073032

Inbound Relationships Type Active Source Characteristic Refinability Group
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has TPUU True Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Inferred relationship Some 1
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device has TPUU True Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Inferred relationship Some 1
Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices has TPUU True Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Inferred relationship Some 1
Bydureon BCise 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices has TPUU True Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start